Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 3, 2002, Pages 320-328

  Greenberg, Alissa K ^a   Hu, Jing ^a   Basu, Sharmila ^a   Hay, John ^a   Reibman, Joan ^a   Yie, Ting An ^a   Tchou Wong, Kam Meng ^a   Rom, William N ^a   Lee, Theodore C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036729435     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4710     Document Type: Article

References (57)

1. Steroid receptor regulated transcription of specific genes and gene networks
2. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation
3. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
4. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms
5. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: Differential effects on cell cycle regulatory proteins
6. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids
7. Glucocorticoid inhibition of fibroblast proliferation and regulation of the cyclin kinase inhibitor p21Cip1
8. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells
9. Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells
10. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha
11. Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early G1 block in cell cycle progression
12. Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells
13. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids
14. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice
15. The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones
16. Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene- induced neoplasia of the lung and forestomach of female A/J mice
17. Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice
18. Studies of chemopreventive effects of budenoside on benzo[a]pyrene-induced neoplasia of the lung of female A/J mice
19. Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol
20. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
21. Cyclin D1 is a nuclear protein required for cell cycle progression in G1
22. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle
23. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
24. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system
25. New insights into the control of MAP kinase pathways
26. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts
27. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation
28. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
29. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase
30. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus
31. Signalling pathways: Jack of all cascades
32. Signal transduction through MAP kinase cascades
33. Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene
34. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity
35. p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells
36. Receptors from glucocorticoid-sensitive lymphoma cells and two clases of insensitive clones: Physical and DNA-binding properties
37. Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium
38. Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines
39. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle
40. Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells
41. Glucocorticoid regulation of G1 cyclin-dependent kinase genes in lymphoid cells
42. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins
43. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes
44. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes
45. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases
46. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes
47. The functions of Myc in cell cycle progression and apoptosis
48. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells
49. Role of the CCAAT/enhancer binding protein-alpha transcription factor in the glucocorticoid stimulation of p21waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells
50. Synergistic effects of dexamethasone and genistein on the expression of Cdk inhibitor p21WAF1/CIP1 in human hepatocellular and colorectal carcinoma cells
51. Glucocorticoid regulation of transcription of the c-myc cellular protooncogene in P1798 cells
52. Glucocorticoid regulation of c-myc promoter utilization in P1798 T- lymphoma cells
53. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis
54. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
55. Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I)
56. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation
57. Regulation of Rb and E2F by signal transduction cascades: Divergent effects of JNK1 and p38 kinases